Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-01 @ 3:03 PM
Study NCT ID:
NCT04887805
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2021-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Pancreatic Ductal Adenocarcinoma | View |
| None | Stage II Pancreatic Cancer AJCC v8 | View |
| None | Stage IIA Pancreatic Cancer AJCC v8 | View |
| None | Stage IIB Pancreatic Cancer AJCC v8 | View |
| None | Stage III Pancreatic Cancer AJCC v8 | View |
| None | Stage IV Pancreatic Cancer AJCC v8 | View |
| None | Unresectable Pancreatic Ductal Adenocarcinoma | View |
Keywords: